Empowered Funds’s Merck MRK Stock Holding History

Empowered Funds’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,385	Closed	-$5.04M	–	638
2022 Q4	$5.04M	Buy	+45,385	New	+$4.64M	0.33%	85

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Empowered Funds's MRK Position: Q2 2026 in Review

Empowered Funds increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $8.09M and bringing the position to 576,918 shares worth $74.1M. The position accounts for 0.39% of the portfolio, ranked #35.

Empowered Funds first reported a position in MRK in Q3 2022 and has held it in 15 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Empowered Funds held 576,918 shares of Merck worth $74.1M as of Q2 2026.
Empowered Funds bought 69,103 Merck shares in Q2 2026, an estimated $8.09M.
Merck made up 0.39% of Empowered Funds's portfolio in Q2 2026, its #35 holding.
Empowered Funds first reported a position in Merck in Q3 2022 and has held it in 15 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.